{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:05:10Z","timestamp":1780340710659,"version":"3.54.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014355","name":"Nirma University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014355","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.biopha.2017.10.137","type":"journal-article","created":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T00:17:14Z","timestamp":1510013834000},"page":"919-927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Magnesium valproate ameliorates type 1 diabetes and cardiomyopathy in diabetic rats through estrogen receptors"],"prefix":"10.1016","volume":"97","author":[{"given":"Samir","family":"Rabadiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shradhha","family":"Bhadada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashvin","family":"Dudhrejiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devendra","family":"Vaishnav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhoomika","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2017.10.137_bib0005","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.2337\/dc13-S067","article-title":"Diagnosis and classification of diabetes mellitus","volume":"36","author":"American Diabetes A","year":"2013","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.biopha.2017.10.137_bib0010","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s00125-012-2822-8","article-title":"Cardiotrophin 1 protects beta cells from apoptosis and prevents streptozotocin-induced diabetes in a mouse model","volume":"56","author":"Jim\u00e9nez-Gonz\u00e1lez","year":"2013","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.biopha.2017.10.137_bib0015","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"issue":"S5","key":"10.1016\/j.biopha.2017.10.137_bib0020","first-page":"S1","article-title":"The rising global burden of diabetes and its complications: estimates and projections to the year 2010","volume":"5","author":"Amos","year":"1997","journal-title":"Diabet. Med."},{"issue":"10","key":"10.1016\/j.biopha.2017.10.137_bib0025","first-page":"390","article-title":"Pathogenesis of renal microvascular complications in diabetes mellitus","volume":"60","author":"Veldman","year":"2002","journal-title":"Neth. J. Med."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2017.10.137_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2012.09.034","article-title":"Aldosterone and angiotensin: role In diabetes and cardiovascular diseases","volume":"697","author":"Patel","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2017.10.137_bib0035","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/0960327112450885","article-title":"Diabetic cardiomyopathy: pathophysiological mechanisms and cardiac dysfunction","volume":"32","author":"Goyal","year":"2013","journal-title":"Hum. Exp. Toxicol."},{"issue":"50","key":"10.1016\/j.biopha.2017.10.137_bib0040","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/1479164113485250","article-title":"The choice of anti-hypertensive agents in diabetic subjects","volume":"10","author":"Patel","year":"2013","journal-title":"Diab. Vas. Dis. Res."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.137_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1472-8206.2012.01051.x","article-title":"Therapeutic implications of small interfering RNA in cardiovascular diseases","volume":"27","author":"Raghunathan","year":"2013","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2017.10.137_bib0050","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/CIRCRESAHA.108.190397","article-title":"Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor\u2013dependent pathway that increases calcineurin degradation","volume":"104","author":"Donaldson","year":"2009","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.biopha.2017.10.137_bib0055","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1172\/JCI44564","article-title":"Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents beta cell failure in rodent models of type 2 diabetes","volume":"121","author":"Tiano","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.biopha.2017.10.137_bib0060","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/FJC.0b013e3180544527","article-title":"The pathway-selective estrogen receptor ligand WAY-169916 reduces infarct size after myocardial ischemia and reperfusion by an estrogen receptor dependent mechanism","volume":"49","author":"Booth","year":"2007","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2017.10.137_bib0065","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1210\/me.2010-0154","article-title":"Estrogen receptor-beta prevents cardiac fibrosis","volume":"24","author":"Pedram","year":"2010","journal-title":"Mol. Endocrinol."},{"issue":"2","key":"10.1016\/j.biopha.2017.10.137_bib0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.14712\/fb2007053020037","article-title":"Valproic acid, a molecular lead to multiple regulatory pathways","volume":"53","author":"Kostrouchova","year":"2007","journal-title":"Folia Biol. (Praha)"},{"issue":"1","key":"10.1016\/j.biopha.2017.10.137_bib0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mce.2009.09.011","article-title":"The histone deacetylase inhibitor valproic acid (VPA) confers an estrogen-sensitive 'phenotype' to estrogen receptor-negative breast cancer cells MDA-MB 231","volume":"314","author":"Fortunati","year":"2008","journal-title":"Mol. Cell. Endocrinol."},{"issue":"10","key":"10.1016\/j.biopha.2017.10.137_bib0080","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1158\/1535-7163.MCT-07-0197","article-title":"The relevance of estrogen receptor-beta expression to the antiproliferative effects observed with histone deacetylase inhibitors and phytoestrogens in prostate cancer treatment","volume":"6","author":"Stettner","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2017.10.137_bib0085","unstructured":"W.C. Holberg III, N.B. Malkar, D.J. Nelson, inventors, Biolink Life Sciences, Inc., assignee, Methods for the Preparation, Formulation and Use of Lithium Valproate, United States of America (2010)."},{"key":"10.1016\/j.biopha.2017.10.137_bib0090","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejphar.2014.01.063","article-title":"Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus","volume":"728","author":"Patel","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2017.10.137_bib0095","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11010-008-9772-y","article-title":"Effect of telmisartan on cardiovascular complications associated with STZ-diabetic rats","volume":"314","author":"Goyal","year":"2008","journal-title":"Mol. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.biopha.2017.10.137_bib0100","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/FJC.0b013e3181be75cc","article-title":"Investigation into the cardiac effects of spironolactone in the experimental model of type 1 diabetes","volume":"54","author":"Goyal","year":"2009","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2017.10.137_bib0105","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1734-1140(11)70611-9","article-title":"Beneficial role of telmisartan on cardiovascular complications associated with STZ-induced type-2 diabetic rats","volume":"63","author":"Goyal","year":"2011","journal-title":"Pharmacol. Rep."},{"issue":"08","key":"10.1016\/j.biopha.2017.10.137_bib0110","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/s-0033-1345168","article-title":"Effect of spironolactone on cardiovascular complications associated with type-2 diabetes in rats","volume":"121","author":"Patel","year":"2013","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"5","key":"10.1016\/j.biopha.2017.10.137_bib0115","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/10641963.2013.827699","article-title":"Type 2 diabetes induced cardiovascular complications: comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril","volume":"36","author":"Patel","year":"2014","journal-title":"Clin. Exp. Hypertens."},{"issue":"11","key":"10.1016\/j.biopha.2017.10.137_bib0120","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1177\/0960327112446817","article-title":"Perindopril protects against streptozotocin induced hyperglycemic myocardial damage\/alterations","volume":"31","author":"Patel","year":"2012","journal-title":"Hum. Exp. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2017.10.137_bib0125","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.pharep.2014.02.004","article-title":"Beneficial role of tamoxifen in experimentally induced cardiac hypertrophy","volume":"66","author":"Patel","year":"2014","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.137_bib0130","first-page":"11","article-title":"Comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril on diabetes induced cardiovascular complications in type 1 diabetes in rats","volume":"19","author":"Goyal","year":"2011","journal-title":"Int. J. Diabetes Metab."},{"issue":"2","key":"10.1016\/j.biopha.2017.10.137_bib0135","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/AC.67.2.2154211","article-title":"Beneficial role of spironolactone, telmisartan and their combination on isoproterenol induced cardiac hypertrophy","volume":"67","author":"Goyal","year":"2012","journal-title":"Acta Cardiol."},{"issue":"10","key":"10.1016\/j.biopha.2017.10.137_bib0140","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1139\/cjpp-2013-0348","article-title":"Beneficial role of tamoxifen in isoproterenol induced myocardial infarction","volume":"92","author":"Rayabarapu","year":"2014","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2017.10.137_bib0145","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/S0021-9258(19)45228-9","article-title":"The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase","volume":"247","author":"Misra","year":"1972","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.137_bib0150","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","article-title":"Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver","volume":"582","author":"Moron","year":"1979","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.biopha.2017.10.137_bib0155","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.137_bib0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1472-6882-8-55","article-title":"Neuroprotective efficacy and therapeutic window of curcuma oil in rat embolic stroke model","volume":"8","author":"Dohare","year":"2008","journal-title":"BMC Complement. Altern. Med."},{"issue":"2","key":"10.1016\/j.biopha.2017.10.137_bib0165","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reactions","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"issue":"12","key":"10.1016\/j.biopha.2017.10.137_bib0170","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1093\/jn\/131.12.3160","article-title":"Gamma-linolenic acid restores renal medullary thick ascending limb Na+, K+-ATPase activity in diabetic rats","volume":"131","author":"Tsimaratos","year":"2001","journal-title":"J. Nutr."},{"issue":"3","key":"10.1016\/j.biopha.2017.10.137_bib0175","first-page":"57","article-title":"Experimental hypothyroidism increases content of collagen and glycosaminoglycans in the heart","volume":"60","author":"Drobnik","year":"2009","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2017.10.137_bib0180","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/948427","article-title":"Evaluation of buspirone on streptozotocin induced type 1 diabetes and its associated complications","volume":"2014","author":"Raghunathan","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"3","key":"10.1016\/j.biopha.2017.10.137_bib0185","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/CIRCULATIONAHA.109.868729","article-title":"Estrogen receptor-\u03b2 activation results in S-nitrosylation of proteins involved in cardioprotection","volume":"120","author":"Lin","year":"2009","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.biopha.2017.10.137_bib0190","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/CIRCRESAHA.110.236687","article-title":"Estrogen signaling and cardiovascular disease","volume":"109","author":"Murphy","year":"2011","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.biopha.2017.10.137_bib0195","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1464-5491.2005.01499.x","article-title":"Animal models of diabetes mellitus","volume":"22","author":"Rees","year":"2005","journal-title":"Diabet. Med."},{"issue":"4","key":"10.1016\/j.biopha.2017.10.137_bib0200","doi-asserted-by":"crossref","first-page":"e2069","DOI":"10.1371\/journal.pone.0002069","article-title":"Pancreatic insulin content regulation by the estrogen receptor ER\u03b1","volume":"3","author":"Alonso-Magdalena","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.10.137_bib0205","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.2337\/db12-1562","article-title":"Antidiabetic actions of an estrogen receptor b selective agonist","volume":"62","author":"Alonso-Magdalena","year":"2013","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.biopha.2017.10.137_bib0210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-8741(02)00059-4","article-title":"Medicinal plants of India with anti-diabetic potential","volume":"81","author":"Grover","year":"2002","journal-title":"J. Ethnopharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2017.10.137_bib0215","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.fct.2005.04.004","article-title":"Antihyperlipidemic effect of Eugenia jambolanaseed kernel on streptozotocin-induced diabetes in rats","volume":"43","author":"Ravi","year":"2005","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.137_bib0220","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2337\/diacare.4.1.76","article-title":"Relationships between control and serum lipids in juvenile-onset diabetes","volume":"4","author":"Glasgow","year":"1981","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.biopha.2017.10.137_bib0225","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/ajcn\/76.6.1191","article-title":"Beneficial role of dietary phytoestrogens in obesity and diabetes","volume":"76","author":"Bhathena","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.biopha.2017.10.137_bib0230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-5996-1-17","article-title":"Effect of Carnitine and herbal mixture extract on obesity induced by high fat diet in rats","volume":"1","author":"Amin","year":"2009","journal-title":"Diabetol. Metab. Syndr."},{"issue":"11","key":"10.1016\/j.biopha.2017.10.137_bib0235","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1248\/bpb.31.2045","article-title":"Ameliorative effect of Captopril and Valsartan on an animal model of diabetic cardiomyopathy","volume":"31","author":"Zhang","year":"2008","journal-title":"Biol. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.biopha.2017.10.137_bib0240","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1124\/jpet.104.082867","article-title":"The acute estrogenic dilation of rat aorta is mediated solely by selective estrogen receptor-\u03b1 agonists and is abolished by estrogen deprivation","volume":"313","author":"Bolego","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2017.10.137_bib0245","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Epstein","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2017.10.137_bib0250","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0006-8993(99)02439-7","article-title":"Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappa B","volume":"857","author":"Ichiyama","year":"2000","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.biopha.2017.10.137_bib0255","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1096\/fj.03-0736com","article-title":"Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene","volume":"18","author":"Tschope","year":"2004","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.biopha.2017.10.137_bib0260","doi-asserted-by":"crossref","first-page":"H968","DOI":"10.1152\/ajpheart.00891.2006","article-title":"Inhibition of histone deacetylase on ventricular remodeling in infarcted rats","volume":"293","author":"Lee","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2017.10.137_bib0265","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nrendo.2009.271","article-title":"Blockade of interleukin 1 in type 1 diabetes mellitus","volume":"6","author":"Mandrup-Poulsen","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"issue":"9","key":"10.1016\/j.biopha.2017.10.137_bib0270","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.2337\/diacare.28.9.2255","article-title":"Electrocardiographic left ventricular hypertrophy in type 1 diabetes: prevalence and relation to coronary heart disease and cardiovascular risk factors: the Eurodiab IDDM Complications Study","volume":"28","author":"Giunti","year":"2005","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.biopha.2017.10.137_bib0275","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1161\/01.ATV.0000223344.11128.23","article-title":"Estrogen receptor beta protects the murine heart against left ventricular hypertrophy","volume":"26","author":"Babiker","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"22","key":"10.1016\/j.biopha.2017.10.137_bib0280","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1161\/CIRCULATIONAHA.106.625467","article-title":"Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy","volume":"113","author":"Kong","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2017.10.137_bib0285","article-title":"Sodium butyrate controls cardiac hypertrophy in experimental models of rats","author":"Patel","year":"2017","journal-title":"Cardiovasc. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2017.10.137_bib0290","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1139\/cjpp-2016-0542","article-title":"Selective inhibition of HDAC2 by magnesium valproate attenuates cardiac hypertrophy","volume":"95","author":"Raghunathan","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2017.10.137_bib0295","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1152\/jappl.1999.86.3.812","article-title":"Alterations of heart function and Na+-K+-ATPase activity by etomoxir in diabetic rats","volume":"86","author":"Kato","year":"1999","journal-title":"J. Appl. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2017.10.137_bib0300","first-page":"222","article-title":"Diabetes- and semi-starvation-induced changes in metabolism and regulation of Na+ K+-ATPase in rat heart","volume":"16","author":"Ziegelhoffer","year":"2003","journal-title":"Diabetes Nutr. Metab."},{"issue":"6","key":"10.1016\/j.biopha.2017.10.137_bib0305","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/CS20040057","article-title":"Diabetic cardiomyopathy: mechanisms, diagnosis and treatment","volume":"107","author":"Hayat","year":"2004","journal-title":"Clin. Sci. (Lond.)"},{"issue":"4","key":"10.1016\/j.biopha.2017.10.137_bib0310","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.phrs.2004.10.012","article-title":"Altered redox status in patients with diabetes mellitus type I","volume":"51","author":"Gil-del Valle","year":"2005","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.biopha.2017.10.137_bib0315","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jacc.2005.09.050","article-title":"The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy","volume":"47","author":"Asbun","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2017.10.137_bib0320","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brainres.2007.08.036","article-title":"Estrogen suppresses brain mitochondrial oxidative stress in female and male rats","volume":"1176","author":"Razmara","year":"2007","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/j.biopha.2017.10.137_bib0325","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1073\/pnas.0712051105","article-title":"HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimen","volume":"105","author":"Li","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2017.10.137_bib0330","doi-asserted-by":"crossref","first-page":"e013","DOI":"10.1621\/nrs.04013","article-title":"Estrogen signaling in the cardiovascular system","volume":"4","author":"Kim","year":"2006","journal-title":"Nucl. Recept. Signal."},{"issue":"17","key":"10.1016\/j.biopha.2017.10.137_bib0335","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1016\/0006-2952(86)90492-2","article-title":"Inhibition of hexonate dehydrogenase and aldose reductase from bovine retina by sorbinil, statil, M79175 and valproate","volume":"35","author":"Poulsom","year":"1986","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2017.10.137_bib0340","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.pnpbp.2006.11.019","article-title":"Sodium valproate at therapeutic concentrations changes Ca2+ response accompanied with its weak inhibition of protein kinase C in human astrocytoma cells","volume":"31","author":"Kurita","year":"2007","journal-title":"Prog. Neuropshychopharmacol. Biol. Psychiatry"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217342956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217342956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:22:51Z","timestamp":1780338171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217342956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":68,"alternative-id":["S0753332217342956"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.10.137","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Magnesium valproate ameliorates type 1 diabetes and cardiomyopathy in diabetic rats through estrogen receptors","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.10.137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}